InflaRx (IFRX) Other Non-Current Assets (2016 - 2026)

InflaRx's (IFRX) quarterly Other Non-Current Assets came in at $162958.4 in Q1 2026, down 18.88% year-on-year from $200882.6 in Q1 2025, and down 7.41% quarter-over-quarter from $176001.1 in Q4 2025.

InflaRx (IFRX) Other Non-Current Assets (2016 - 2026) Analysis & Trends

InflaRx has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $162958.4 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $162958.4, down 18.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $162958.4 (down 18.88% YoY), and the FY2025 annual result was $176001.1, down 96.42% from the prior year.
  • Other Non-Current Assets came in at $162958.4 for Q1 2026 at InflaRx, down from $176001.1 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $8.1 million in Q1 2023 to a low of -$3.4 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $276803.8 (2023), against an average of $1.8 million.
  • Peak annual rise in Other Non-Current Assets reached 1675.82% in 2024, while the deepest fall reached 101.7% in 2024.
  • InflaRx's Other Non-Current Assets stood at -$3.4 million in 2022, then soared by 108.2% to $276803.8 in 2023, then surged by 1675.82% to $4.9 million in 2024, then tumbled by 96.42% to $176001.1 in 2025, then declined by 7.41% to $162958.4 in 2026.
  • The last three Other Non-Current Assets figures came in at $162958.4 (Q1 2026), $176001.1 (Q4 2025), and $192259.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 289.41 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 60,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 162,958.43

Historic Data

Download Data
DateValue
Mar 31, 2026 162,958.43
Dec 31, 2025 176,001.05
Sep 30, 2025 192,259.29
Jun 30, 2025 201,167.35
Mar 31, 2025 200,882.58
Dec 31, 2024 4.92 Mn
Sep 30, 2024 4.08 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 -137,475.82
Dec 31, 2023 276,803.83
Sep 30, 2023 4.86 Mn
Jun 30, 2023 6.86 Mn
Mar 31, 2023 8.07 Mn
Dec 31, 2022 -3.38 Mn
Sep 30, 2022 3.11 Mn
Jun 30, 2022 652,871.17
Mar 31, 2022 -1.58 Mn
Dec 31, 2021 -8.12 Mn
Sep 30, 2021 -1.37 Mn
Jun 30, 2021 207,135.89